GSK’s Ojjaara Scores Myelofibrosis Nod After Round-The-World Journey

 
• By Alaric DeArment
  
The FDA approved GSK's Ojjaara for myelofibrosis with anemia • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip